← Leaderboards
Masataka Suzuki
Baylor College Of Medicine
$902,239
Attributed
$902,239
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2010–15$250K$187.5K$125K$62.5K$0
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$902,239 · 2
By mechanism
R00$738,286 · 1
K99$163,953 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Brendan Hl Lee$62,781,623
- Philip Ng$7,705,481
- Arthur L. Beaudet$51,053,980
- Huda Y Zoghbi$38,140,328
- Paul F. Bray$17,101,662
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteAbstractingAdenovirus VectorA MouseAnimal ModelAnimalsAntibody FormationAttenuatedAttenuationBloodBlood Coagulation DisordersBlood TreatmentCanis FamiliarisCell CycleCellsCell TypeChronicClinicClinically RelevantClinical ResearchClinical TreatmentClinical TrialsCoagulation ProcessCode
Grant awards (5)
Blocking the immune response to HDAd for Hemophilia A gene therapy$245,266
R00 · FY2015 · HL · contact PI
Blocking the immune response to HDAd for Hemophilia A gene therapy$244,020
R00 · FY2014 · HL · contact PI
Blocking the immune response to HDAd for Hemophilia A gene therapy$249,000
R00 · FY2013 · HL · contact PI
Blocking the immune response to Helper-dependent adenovirus vector for Hemophilia$83,188
K99 · FY2011 · HL · contact PI
Blocking the immune response to Helper-dependent adenovirus vector for Hemophilia$80,765
K99 · FY2010 · HL · contact PI